期刊文献+

肿瘤坏死因子受体1在中耳胆脂瘤上皮中的表达 被引量:3

Expression of tumour necrosis factor receptor 1 in middle ear cholesteatoma
下载PDF
导出
摘要 目的研究肿瘤坏死因子受体1(TNFR1)在中耳继发性胆脂瘤上皮的表达,探讨其在胆脂瘤型中耳炎的发病机制中的作用。方法分别采用免疫组化法和Western blot技术检测TNFR1在36例中耳胆脂瘤组织及20例正常外耳道皮肤组织中的表达情况。结果TNFR1在36例胆脂瘤上皮各层细胞中均有强表达,定位于胞膜和胞质,而外耳道皮肤表达较弱甚至没有表达,TNFR1在胆脂瘤上皮中的蛋白表达水平较外耳道皮肤显著增高,差异有统计学意义(P<0.01)。结论胆脂瘤上皮中TNFR1表达较外耳道皮肤显著增高,肿瘤坏死因子可能通过与TNFR1相结合而导致胆脂瘤上皮细胞的过度增殖及凋亡。 Objective To explore the expression of turnout necrosis factor receptor 1 in middle ear cholesteatoma, and lo evaluate its roles in the pathogenetic mechanism of middle ear cholesteatoma. Methods We used immunohistochemistry and Western blot to examine the expression of turnout necrosis factor receptor 1 in thirty-six middle ear cholesteatomas, and twenty samples of normal external ear canal skin. Results The expression of turnout necrosis factor receptor 1 was extremely higher in middle ear cholesteatoma than in normal external canal skin (P 〈 0.01 ). Conclusion Turnout necrosis factor receptor 1 may play an important role in the occurrence and development of cholesteatoma, which may be combined with turnout necrosis factor, leading to proliferation and apoplosis of middle ear cholesteatoma epithelial cells.
出处 《中华耳科学杂志》 CSCD 2007年第1期94-97,共4页 Chinese Journal of Otology
关键词 胆脂瘤 中耳 肿瘤坏死因子受体1 Middle ear cholesteatoma Tumour necrosis faclor receptor 1
  • 相关文献

参考文献14

  • 1[1]Bujia J,Kim C,Holly A,et al.Epidermal growth factor receptor (EGF-R) in human middle ear cholesteatoma:an analysis of protein production and gene expression.Am J Otol,1996,17 (2):203-206.
  • 2[2]Bujia J,Kim C,Ostos-Aumente P,et al.Enhanced epithelial proliferation due to elevated levels of interleukin-1 receptors in middle ear cholesteatomas.Eur Arch Otorhinolaryngol,1997,254 (1):6-8.
  • 3[3]Park HJ,Park K.Expression of Fas/APO-1 and apoptosis of keratinocytes in human cholesteatoma.Laryngoscope,1999,109 (4):613-616.
  • 4[4]Yan SD,Huang CC.Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro.Ann Otol Rhinol Larygol,1991,100 (2):157-161.
  • 5[5]Brownlee M.Biochemistry and molecular cell biology of diabetic complications.Nature,2001,414 (6865):813-820.
  • 6[6]Yetiser S,Satar B,Aydin N.Expression of epidermal growth factor,tumor necrosis factor-alpha,and interleukin-1alpha in chronic otitis media with or without cholesteatoma.Otol Neurotol,2002,23 (5):647-652.
  • 7[7]Chodynicki S,Soroczynska J.TNF alpha in serum of patients with cholesteatoma.Otolaryngol Pol,1994,48 (3):279-281.
  • 8[8]Akimoto R,Pawankar R,Yagi T,et al.Acquired and congenital cholesteatoma:determination of tumor necrosis factor alpha,intracellular adhesion molecule-1,interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process.ORL J Otorhinolaryngol Relat Spec,2000,62 (5):257-265.
  • 9[9]Lavrik I,Golks A,Krammer PH.Death receptor signaling.J Cell Sci,2005,118 (Pt 2):265-267.
  • 10[10]Schneider-Brachert W,Tchikov V,Neumeyer J,et al.Compartmentalization of TNF receptor 1 signaling:internalized TNF receptosomes as death signaling vesicles.Immunity,2004,21 (3):415-428.

同被引文献20

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部